Connect with us
Invega Hafyera
Company
Indications
- Treatment of schizophrenia in adults after they have been adequately treated with: • A once-a-month paliperidone palmitate extended-release injectable suspension (e.g., INVEGA SUSTENNA) for at least four months or • An every-three-month paliperidone palmitate extended-release injectable suspension (e.g., INVEGA TRINZA) for at least one three-month cycle.
04/07/2023 - Epic, Not All Adverse Effects Are Allergic!
11/18/2022 - The Myth of Location
04/14/2022 - "Right" to an In-Person Encounter
09/02/2021 - Half Year, Uh
07/08/2021 - No Freedom of Information at FDA
Daily Tweets
CNS Drug: #CNSDOD
Notable Person: #BHCPOD
Phobia: #BNphobia
Term: #BHCTOD
National Conference Tweetchats
12/7-10 AAAP
#AAAP2023